Fundraising FoxDelta Life Science
4 known investors
Find your way into Delta Life Science
Sign up to see every warm intro you have to Delta Life Science
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Delta Life Science team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Delta Life Science develops the inQuiQ, a label-free biosensing instrument that uses integrated photonics to measure biomolecular binding affinity and kinetics (KD, ka, kd) in real time from small sample volumes. It serves academic research institutes, biotech R&D, and CROs/CDMOs as an alternative to surface plasmon resonance and bio-layer interferometry for applications such as antibody characterization, small molecule and fragment screening, and PROTAC/molecular glue analysis.
Investors · 4
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMay 2023
i&i Biotech Fund, InnovationQuarter, Oost NL, PhotonDelta
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Delta Life Science do?
- Delta Life Science develops the inQuiQ, a label-free biosensing instrument that uses integrated photonics to measure biomolecular binding affinity and kinetics (KD, ka, kd) in real time from small sample volumes. It serves academic research institutes, biotech R&D, and CROs/CDMOs as an alternative to surface plasmon resonance and bio-layer interferometry for applications such as antibody characterization, small molecule and fragment screening, and PROTAC/molecular glue analysis.
- Who are Delta Life Science's investors?
- Delta Life Science's investors include i&i Biotech Fund, Oost NL.